ProCE Banner Activity

Myelodysplastic Syndromes: Guidance on the Optimal Management of Older Adult Patients

Slideset Download
Myelodysplastic syndromes occur in an older patient population. This downloadable slideset from a live webinar series offers expert guidance on the needs of older patients with MDS.

Released: October 21, 2021

Expiration: October 20, 2022

No longer available for credit.

Share

Faculty

Jamile Shammo

Jamile Shammo, MD, FASCP, FACP

Professor of Medicine and Pathology
Division of Hematology, Oncology, and Stem Cell Transplant
Director, MDS/MPN/Aplastic Anemia Program 
Rush University Medical Center
Chicago, Illinois

Provided by

Provided by Rush University Medical Center in partnership with Clinical Care Options, LLC, and the MDS Foundation.
ProCE Banner

Supporters

Supported by an educational grant from

Bristol Myers Squibb

Partners

MDS Foundation

ProCE Banner

Program Director Disclosure

Program Director

Jamile Shammo, MD, FASCP, FACP

Professor of Medicine and Pathology
Division of Hematology, Oncology, and Stem Cell Transplant
Director, MDS/MPN/Aplastic Anemia Program 
Rush University Medical Center
Chicago, Illinois

Jamile Shammo, MD, FASCP, FACP, has disclosed that she has received consulting fees from Alexion, Apellis, Bristol-Myers Squibb, Incyte, Novartis, Sanofi, and Takeda; has received funds for research support from AbbVie, Alexion, AstraZeneca, Bristol-Myers Squibb, CTI, Incyte, Kartos, Novartis, and Stemline; has received fees from non-CME/CE activities from Alexion, Bristol-Myers Squibb, Incyte, and Sanofi; and owns stock in AbbVie, Baxter, and Takeda.